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Abstract
Background: Leptin is an adipocyte-derived hormone that plays a critical role in energy homeostasis and lipid metabolism.
Overnutrition-associated obesity is known to be accompanied by hyperleptinemia. However, the physiological actions of
leptin in the metabolic responses to high-fat diet (HFD) intake remain to be completely elucidated. Here we characterized
the metabolic features of mice fed high-fat diets and investigated the impact of leptin upon the lipogenic program which
was found to be suppressed by HFD feeding through a proteomics approach.
Results: When maintained on two types of high-fat diets for up to 16 weeks, mice with a higher fat intake exhibited
increased body fat accumulation at a greater pace, developing more severely impaired glucose tolerance. Notably, HFD
feeding at 4 weeks elicited the onset of marked hyperleptinemia, prior to the occurrence of apparent insulin resistance and
hyperinsulinemia. Proteomic analysis revealed dramatically decreased expression of lipogenic enzymes in the white adipose
tissue (WAT) from HFD-fed mice, including ATP-citrate lyase (ACL) and fatty acid synthase (FAS). The expression of ACL and
FAS in the liver was similarly suppressed in response to HFD feeding. By contrast, HFD-induced downregulation of hepatic
ACL and FAS was significantly attenuated in leptin receptor-deficient db/db mice. Furthermore, in the liver and WAT of wild
type animals, intraperitoneal leptin administration was able to directly suppress the expression of these two lipogenic
enzymes, accompanied by reduced triglyceride levels both in the liver and serum.
Conclusions: These results suggest that leptin contributes to the metabolic responses in adaptation to overnutrition
through suppressing the expression of lipogenic enzymes, and that the lipogenic pathway represents a key targeted
peripheral component in exerting leptin’s liporegulatory actions.
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Introduction
As a major risk factor for type 2 diabetes and cardiovascular
complications, obesity is currently reaching epidemic proportions
worldwide [1], largely stemming from complex interactions
between genetic factors and environmental influences such as
overnutrition. In mammals, multiple mechanisms act in an
integrated manner to balance energy storage and expenditure,
and chronic disruption of energy balance leads to excessive
accumulation of fat in the adipose tissue [2]. In addition to energy
storage, the adipose tissue is also known to serve as a critical
endocrine organ that releases a variety of adipokines, eliciting an
array of metabolic effects on lipid and glucose metabolism [3].
Leptin is an adipocyte-secreted hormone that plays a critical role
in energy homeostasis [4–6]. Primarily acting through activation
of leptin receptor-expressing neurons in the hypothalamus [7–11],
leptin functions to control energy balance and the fat mass via
reducing food intake and increasing energy expenditure. On the
other hand, leptin can also exert crucial metabolic effects upon
lipid metabolism, preventing triglyceride (TG) accumulation in
peripheral tissues [12]. For instance, it has been shown that leptin
is able to stimulate fatty acid oxidation through activation of AMP-
activated protein kinase (AMPK), subsequently inhibiting acetyl-
CoA carboxylase (ACC) activity, in the skeletal muscle [13].
Increased circulating levels of leptin (i.e. hyperleptinemia) have
been found to be associated with obesity induced by overnutrition,
as in the case of chronic intake of high-fat diet [14]. However,
whether hyperleptinemia exerts its metabolic liporegulatory
actions and represents an adaptive response to chronic overnutri-
tion has yet to be completely understood.
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body’s energy storage and is coordinately controlled in response to
nutritional, hormonal and metabolic stimuli [15,16]. This cytosolic
process occurs with the initial conversion of citrate to acetyl-CoA
catalyzed by ATP-citrate lyase (ACL) [17,18]. Acetyl-CoA is
further converted to malonyl-CoA by ACC, the rate-limiting step
in de novo fatty acid synthesis [19]. Malonyl-CoA is then used as the
substrate of fatty acid synthase (FAS) for fatty acid synthesis [20].
Recently, adipose tissue lipogenesis has been shown to be
controlled by leptin via STAT3-independent central mechanisms
[21]; whereas a liporegulatory role of hyperleptinemia has been
implicated in non-adipose tissues, affecting lipogenesis and fatty
acid oxidation [22]. Therefore, it is likely that leptin may act upon
the peripheral lipogenic program in the face of overnutrition to
mediate body’s metabolic adaptation responses.
Using the well-established HFD-induced obesity mouse model,
we employed a proteomic approach to examine the global protein
expression changes in the WAT as associated with the progression
of adiposity. We found that, among protein enzymes involved in
lipid metabolism, the lipogenic enzymes ACL and FAS were
predominantly suppressed in both the WAT and liver in mice
challenged by HFD feeding, in parallel with concomitant onset of
hyperleptinemia. Then we further investigated the impact of leptin
upon the control of lipogenic enzyme expression in the liver and
WAT.
Results
High-fat diet feeding induces hyperleptinemia prior to
hyperinsulinemia and insulin resistance
To characterize the metabolic features that accompany the
progression of adiposity, male C57BL/6 mice were fed low (LFD,
10% fat), high (HFD, 45% fat) and very high (VHFD, 60% fat) fat
diets, respectively. In comparison with control mice fed LFD, mice
fed HFD or VHFD developed overt obesity at 16 weeks, with their
body fat content increased by ,2.5-fold and ,3.8-fold, respectively
(Figure 1A). Whereas HFD feeding for 4 weeks did not show
significant effects, VHFD feeding considerably increased adiposity
(by 1.7-fold as compared to LFD), indicating that intake of higher
dietary fat (60% fat) induces a higher degree of obesity at a faster
pace. Moreover, supporting the close correlation between insulin
resistance and obesity, mice fed VHFD exhibited more pronounced
glucose intolerance at 16 weeks but not at 4 weeks when compared
with LFD-fed animals (Figure 1B). Consistently, marked hyper-
insulinemia was found at 16 weeks in HFD-fed mice, but not at 4
weeks (Figure 1C). In contrast,despite modestincreasesin body fat
mass (by ,70%) in VHFD-fed mice at 4 weeks, a ,7-fold upsurge
in circulating leptin levels was observed relative to LFD-fed mice;
whereas at 16 weeks both HFD and VHFD feeding led to
prominent degrees of hyperleptinemia (Figure 1D). These data
demonstrate thattheonsetofhyperleptinemiaoccurspriortothatof
hyperinsulinemia and insulin resistance during the progressive
development of diet-induced obesity, which may exert metabolic
actions in response to HFD feeding.
Lipogenic enzymes are predominantly suppressed in
response to HFD feeding
To explore the global protein expression features in the WAT of
mice that may manifest the metabolic impact of HFD feeding, we
took a proteomic approach to analyze the adipose protein extracts
from mice fed LFD versus VHFD by quantitative two-dimensional
(2D) polyacrylamide gel electrophoresis (PAGE) (Figure 2A).
Subsequent tryptic peptide analysis by LC-mass spectrometry
identified a total of 33 proteins in mice fed VHFD for 4 weeks and
of 22 proteins in mice fed VHFD for 16 weeks, respectively, that
exhibited significantly altered expression levels (Table 1 and
Supporting Information Table S1). Included among the
proteins upregulated are several stress response- or detoxification-
related proteins (such as heat shock cognate 71 kDa protein) and
cytoskeleton/structural proteins, whereas most of the proteins
showing decreased expression levels were involved in lipid, fatty
acid and carbohydrate metabolism. Notably, lipogenesis-related
enzymes, including ACL, FAS, transketolase and malic enzyme 1
(ME1), displayed the most prominent suppression in response to
VHFD feeding. These enzymes catalyze critical steps in de novo
fatty acid synthesis, either responsible for production of cytosolic
Figure 1. High-fat diet feeding elicits hyperleptinemia prior to hyperinsulimia. C57BL/6 male mice at 6 weeks of age were fed LFD, HFD
and VHFD, respectively. (A) Body fat accumulation was monitored monthly by nuclear magnetic resonance (NMR) and shown as percentage of total
body weight (n=15/group). (B) Glucose tolerance tests were performed in mice at 4 weeks (n=10/group) or 16 weeks (n=15/group) as indicated. (C,
D) Serum concentrations of (C) insulin and (D) leptin were determined in mice maintained on the diets for 4 or 16 weeks (n=3–4/group). All data are
presented as mean6SEM.
*p,0.05 vs. LFD-fed mice.
doi:10.1371/journal.pone.0006884.g001
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generation of NADPH to be consumed in fatty acid synthesis
(Figure 2B). Of interesting note, as analyzed by 2D-PAGE, ACL
protein migrated as differentially charged species, likely arising
from multiple modifications (e.g. phosphorylation). To verify the
downregulated expression of lipogenic enzymes as detected by the
proteomic analysis, quantitative RT-PCR assessment was per-
formed. The mRNA expression levels of both ACL and FAS were
similarly reduced by ,80% in mice fed HFD or VHFD for 4
weeks (Figure 2C).
Then we further examined by immunoblotting the HFD-
induced suppression of ACL and FAS proteins in the WAT, both
of which were markedly reduced at 4 or 16 weeks in HFD- or
VHFD-fed mice (Figure 3A), consistent with their downregulated
mRNA expression levels. Similarly in the liver, the other major
lipogenic organ responsible for fuel conversion and storage, HFD
feeding also led to dramatically suppressed expression of ACL and
FAS proteins (Figure 3B).
Collectively, these data demonstrate that in response to high
dietary fat intake, hyperleptinemia occurs at an early stage during
the progressive accumulation of fat mass, concurrent with marked
suppression of the lipogenic program in the adipose tissues as well
as in the liver. This indicates that leptin may contribute to eliciting
these metabolic changes in an adaptive response to overnutrition.
Leptin signaling deficiency attenuates HFD-induced
suppression of hepatic lipogenic enzymes
To investigate the link between the metabolic effects of hyperlepti-
nemia and the suppression of lipogenic enzymes upon the challenge of
HFD, we examined the impact of HFD feeding in leptin receptor-
Table 1. Proteins with altered expression in the WAT of the HFD-fed mice at 4 weeks.
Accession No. Gene name Description Fold
NP_598798 ATP citrate lyase lipid, fatty acid and isoprenoid metabolism 210.68
NP_032014 Fatty acid synthase lipid, fatty acid and isoprenoid metabolism 24.83
NP_033414 Transketolase pentose-phosphate pathway 22.93
NP_032641 NADP-dependent malic enzyme lipid, fatty acid and isoprenoid metabolism 22.78
NP_034079 Carnitine O-palmitoyltransferase II lipid, fatty acid and isoprenoid metabolism 22.65
NP_033788 Aldose reductase C-compound and carbohydrate metabolism 22.31
AAH94462 Aconitate hydratase, mitochondrial precursor C-compound and carbohydrate metabolism 22.13
NP_031407 Long-chain specific acyl-CoA dehydrogenase lipid, fatty acid and isoprenoid metabolism 22.04
NP_035164 Peroxiredoxin-1 stress response,detoxification 21.90
AAH16619 Pyruvate kinase 3 C-compound and carbohydrate metabolism 21.88
AAF67667 Isovaleryl-CoA dehydrogenase amino acid metabolism 21.79
NP_031409 Short-chain specific acyl-CoA dehydrogenase lipid, fatty acid and isoprenoid metabolism 21.77
NP_032823 Pyruvate carboxylase lipid, fatty acid and isoprenoid metabolism 21.69
AAH39925 Bifunctional purine biosynthesis protein PURH nucleotide/nucleoside/nucleobase metabolism 21.65
NP_080455 Abhydrolase domain-containing protein 5 protein modification 21.55
NP_083060 Coagulation factor XIII A chain precursor protein modification 1.65
NP_033375 Indolethylamine N-methyltransferase C-compound and carbohydrate metabolism 1.68
NP_666232 Gelsolin cytoskeleton/structural proteins 1.69
NP_694708 EH-domain containing 2 cytoskeleton/structural proteins 1.71
NP_036167 Synaptic vesicle membrane protein VAT-1 homolog intracellular transport vesicles 1.72
NP_038534 Eukaryotic initiation factor 4A-II DNA/RNA processing 1.76
AAH66191 Heat shock cognate 71 kDa protein stress response,detoxification 1.80
NP_067248 Creatine kinase B-type amino acid metabolism 1.81
AAH55341 Rab GDP dissociation inhibitor beta-2 cytoskeleton/structural proteins 1.94
NP_075608 Alpha-enolase C-compound and carbohydrate metabolism 2.06
AAC53295 Proteasome activator complex subunit 1 protein/peptide degradation 2.29
NP_031978 Protein disulfide isomerase associated 3 signal transduction 2.35
AAA69475 Peroxiredoxin-2 stress response,detoxification 2.37
CAA31455 Gamma actin-like protein cytoskeleton/structural proteins 2.54
NP_058662 D-3-phosphoglycerate dehydrogenase amino acid metabolism +
AAI08387 Actin-like protein 3 cytoskeleton/structural proteins +
NP_033768 Cysteine-rich secretory protein 1 precursor extracellular matrix component +
NP_033861 Aldose reductase-related protein 1 lipid, fatty acid and isoprenoid metabolism +
Numbers with ‘‘2’’ indicate fold decreases in the VHFD-fed group, or fold increases otherwise. ‘‘+’’ indicates that the protein was only detectable in the WAT from the
VHFD-fed mice. Quantitation was done using the ImageMaster
TM 2D Elite Software (Amersham Biosciences).
doi:10.1371/journal.pone.0006884.t001
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LFD for 4 weeks, db/db mice displayed body weight gain and fat mass
accumulation to a greater extent than their WT littermates (data not
shown). Consistently, hepatic expression of ACL and FAS was
m a r k e d l yr e d u c e di nV H F D - f e dW Tm i c e ;i nc o n t r a s t ,s u p p r e s s i o no f
hepatic ACL and FAS expression was prominently blunted in VHFD-
fed db/db mice (Figure 4). Thus, these results suggest that fully
functional leptin actions are required for HFD-induced suppression of
the lipogenic enzymes in the liver, further supporting the involvement
of leptin in adaptive responses to overnutrition through its suppressing
action on the lipogenic program.
Leptin administration directly suppresses the expression
of lipogenic enzymes
Leptin has been reported to reduce triglyceride content in
peripheral tissues, including liver, muscle and pancreas [22]. To
determine whether leptin exerts its liporegulatory effects through,
at least in part, direct downregulation of lipogenic enzymes, we
injected wild type mice maintained on a normal chow diet
intraperitoneally (i.p.) with leptin twice a day for 4 days. Consistent
with previously documented studies [23], leptin administration
resulted in considerable reductions in food intake and body weight
(Figure 5A, B). At 5 hours post the last injection with leptin,
marked phosphorylation/activation of signal transducer and
activator of transcription 3 (STAT3) were detected in the
hypothalamus as well as in the WAT and liver (Figure 5C). In
parallel, leptin treatment significantly decreased the triglyceride
(TG) levels both in the serum and liver (Figure 5D). Immunoblot
analysis showed that leptin significantly reduced the protein
expression levels of ACL (by ,46%) and FAS (by ,56%) in the
liver (Figure 5E); more dramatic suppression of ACL and FAS
protein expression was also observed in the WAT (Figure 5F).
Figure 2. Identification by proteomic analysis of lipogenic enzymes suppressed in the white adipose tissue in response to the high-
fat diet challenge. (A) Protein extracts of the epididymal fat pad from mice fed LFD vs. VHFD for 4 weeks (n=3/group) were fractionated by 2D
SDS-PAGE. Proteins of interest were subsequently subjected to tryptic peptide identification analysis using LC-mass spectrometry. Shown is a
representative section of the silver-stained 10% 2D SDS-PAGE gel with the migration of ACL protein indicated by the arrows. (B) Schematic diagram of
the sequential steps in de novo lipogenesis as related to the TCA cycle in the mitochondrion. Highlighted by circles are the identified enzymes
displaying predominantly decreased expression levels. (C) Real-time quantitative RT-PCR analysis of the mRNA expression levels of ACL and FAS in the
WAT of mice fed LFD vs. VHFD for 4 weeks, shown as mean6SEM (n=3/group).
*p,0.05 vs. LFD-fed mice.
doi:10.1371/journal.pone.0006884.g002
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pathway represents a key targeted component in exerting leptin’s
liporegulatory actions.
Discussion
As major organs for energy conversion and storage, both the liver
and white adipose tissue play crucial roles in metabolic homeostasis
by responding to body’s nutritional and energy states. In this study,
we show that in an adaptive response to overnutrition (HFD intake),
the early onset of hyperleptinemia most likely contributes to the
suppression of the lipogenic program in the liver and white adipose
tissue; leptin exerts crucial liporegulatory functions via its metabolic
control of the peripheral lipogenic pathway.
Taking a proteomic approach, we attempted to characterize the
global protein expression profiles in the WAT of mice when
challenged with HFD feeding, leading to the identification of
lipogenic enzymes, including ACL and FAS, which exhibited most
predominantly decreased expression patterns. Despite the limited
number of proteins identified by the proteomic strategy that
allowed only for identification of those expressed at abundant
levels, our results are in line with the reported oligonucleotide
microarray profiling studies by Moraes RC et al. [24]. Similar to
the microarray results showing differentially expressed genes in the
WAT of HFD-fed mice after 8 weeks [24], many of the WAT
proteins identified were also found to be down-regulated in HFD-
fed mice, among which included enzymes involved in lipid
metabolism (e.g. FAS and transketolase) and detoxification
processes, as well as cytoskeleton structural components. There-
fore, our proteomic analysis of the WAT revealed similarly broad
changes in the gene expression spectrum in response to HFD
intake. Moreover, the observed suppression in the liver of the
protein expression of the two key lipogenic enzymes, ACL and
FAS, is also consistent with their reduced mRNA expression levels
documented by hepatic cDNA microarray analyses of HFD-fed
obese mice [25,26]. As HFD-induced changes in the WAT
expression of stress response proteins and cytoskeleton compo-
nents may reflect the coordinate response to meet the demand for
Figure 3. High-fat diet feeding suppresses the expression of lipogenic enzymes both in the white adipose tissue and liver. Western
immunoblot analysis of the expression of ACL and FAS in the (A) WAT or (B) liver from mice fed LFD, HFD and VHFD for 4 and 16 weeks, respectively.
Each lane represents the tissue extract from one animal. Bar graphs indicate the relative protein expression levels determined by densitometric
quantification of the immunoblots after normalization to actin or GAPDH. Data are shown as mean6SEM (n=3/group). *p,0.05 vs. LFD-fed mice.
doi:10.1371/journal.pone.0006884.g003
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accordance with the notion that transcriptional adaptation occurs
upon the challenge by high dietary fat intake. The observed
suppression of the endogenous lipogenic program in the adipose
tissue and liver most likely represents an important feature of the
early adaptive responses to the state of overnutrition, whereby
increased leptin levels may exert important regulatory actions.
Multiple mechanisms are thought to mediate the regulatory actions
of leptin on lipid metabolism. Direct peripheral actions by leptin have
been implicated in depleting fat content through increased fatty acid
oxidation as well as suppressed lipogenesis [12,22,27]. Upon HFD
feeding, we observed dramatically increased leptin but normal insulin
levels that paralleled the concurrent suppression of lipogenic enzymes
in the liver and WAT; on the other hand, abrogation of leptin
signaling in db/db mice abolished, at least partially, the suppressing
effects of HFD feeding on hepatic ACL and FAS expression. These
results suggest that HFD-induced hyperleptinemia contributes to the
suppression of the lipogenic program, consistent with previously
reported findings that indicate the requirement of functional leptin
actions for HFD-induced suppression of de novo lipogenesis using the
leptin receptor-defective Zucker diabetic fatty (ZDF) rats [28,29].
Moreover, we observed that direct leptin administration stimulated
the phosphorylation activation of STAT3 not only in the hypothal-
amus, but also in the liver and WAT, paralleled by reduced ACL and
FAS protein expression both in the liver and WAT. Whereas a central
action by leptin hasbeen shown to be criticalto itsmetaboliccontrolof
lipid metabolism [21,30], it remains to be completely clarified whether
leptin exerts its suppressing effects upon the lipogenic program also
through autonomous peripheral mechanisms, or whether the
peripheral STAT3 activation is essentially involved in mediating
leptin’s liporegulatory actions. In addition, leptin has been demon-
strated to result in more pronounced suppression of the expression of
lipogenic genes, including ACL and FAS, as compared with pair-
feeding in leptin-deficient ob/ob mice via hepatic mciroarray analysis
[31], while another study by RT-PCR assessment showed similarly
repressed expression of lipogenic genes, such as ACC and FAS, upon
leptin treatment relative to pair-feeding in ob/ob mice [32]. Thus, it
remains to be completely deciphered whether leptin exerts its action
on the control of lipogenic program in a manner totally independent
of its regulation of food intake.
Obesity is pathogenically associated with the occurrence of
leptin resistance in human as well as in animal models [33,34].
Because our results support that leptin exerts its crucial metabolic
effects through controlling the expression of lipogenic enzymes, it
is conceivable that dysregulated lipogenic pathway may underlie
the deleterious effects of defective leptin signaling upon lipid
metabolism. Indeed, as we have previously demonstrated in db/db
mice, hepatic ACL is dysregulated in the absence of functional
leptin signaling; furthermore, hepatic ACL suppression leads to
marked protection of the obese mice against the development of
liver steatosis [35]. Thus, our results provide physiological
evidence that the lipogenic pathway serves as a key component
in mediating leptin’s regulatory actions in lipid homeostasis.
Materials and Methods
Animal studies
C57BL/6 male mice (Shanghai Laboratory Animal Co. Ltd) and
C57BL/6 db/db male mice (from Model Animal Research Center)
were housed in laboratory cages at a temperature of 2363uC and a
humidityof3565%under a 12-hrdark/lightcycle (lightson at6:30
am) in accredited animal facilities at Shanghai Institutes for
Biological Sciences, CAS. For DIO mouse model, mice were
randomly grouped with free access to one of the three experimental
diets (n=15/group) containing 10 kcal% (LFD), 45 kcal% (HFD)
and 60 kcal% (VHFD) fat, respectively (Research Diets). Total body
fat content was measured by nuclear magnetic resonance (NMR)
using the Minispec Mq7.5 (Bruker). For leptin administration,
individually caged 8-week-old male mice (n=4–5 per group) on
chow diet were first acclimated by i.p. injection of PBS for 5 days,
followed by i.p. injection twice daily (6:00 pm and 8:00 am) with
PBS or recombinant mouse leptin (National Hormone and Peptide
Program) at a dose of 2 mg/kg for 4 days. Mice were sacrificed
5 hours after the eighth injection (at 1:00 pm). Tissues of interest
were snap-frozen in liquid nitrogen immediately after resection and
stored at 280uC. All experimental procedures and protocols were
approved by the Institutional Animal Care and Use Committee of
the Institute for Nutritional Sciences, CAS.
2D SDS-PAGE and protein identification by MS
Proteins extracts (30 mg) from epididymal fat pads were loaded
onto an Immobiline Drystrip IPG gel (Amersham Biosciences,
pH range 3–10 NL), and proteins were separated using the
IPGphor Isoelectric Focusing System (Amersham Biosciences)
according to manufacturer’s instructions. For the second
dimension analysis, the IPG strips were first equilibrated in a
buffer containing 50 mM Tris-HCl, pH 8.8, 6 M urea, 30%
glycerol, 2% SDS, 0.002% bromophenol blue and 1% dithio-
threitol, followed by incubation in the same buffer with 1% DTT
replaced by 2.5% iodoacetamide. Proteins were fractionated by
10% SDS-PAGE and visualized by silver staining, followed by
quantitative analysis using the ImageMaster
TM 2D Elite
Software (Amersham Biosciences). Visualized protein spots of
interest were then excised from Coomassie-blue-stained gels and
subjected to in-gel digestion by trypsin. Recovered peptides for
each protein were analyzed by nanoelectrospray tandem mass
spectrometry using a quadrupole/time-of-flight (Q-TOF) hybrid
mass spectrometer (QSTAR-Pulsar, Applied Biosystems/Sciex
and Bruker-Daltonics AuoFlex TOF-TOF LIFT). The mass
profiles of tryptic peptides were subsequently analyzed via
Figure 4. Attenuation of high-fat diet-induced suppression of
hepatic lipogenic enzymes in db/db mice. (A) Western immunoblot
analysis of ACL and FAS protein levels in the liver of WT and db/db mice
fed LFD vs. VHFD for 4 weeks. (B) Quantification of the relative protein
levels in (A) after normalization to tubulin as the loading control, shown
as mean6SEM (n=2–4/group).
*p,0.05 vs. LFD-fed mice of the same
genotype.
doi:10.1371/journal.pone.0006884.g004
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Protein Database).
Glucose tolerance test (GTT)
After an overnight fast, mice were injected i.p. with glucose at
1 g/kg. Blood was collected from the tail vein at 0, 30, 60, and
120 min after glucose injection, and glucose concentrations were
measured by a glucometer (FreeStyle).
Blood measurements
Serum level of triglycerides was determined by the Serum
Triglyceride Determination Kit (Sigma). Serum concentrations of
Figure 5. Exogenous leptin suppresses the expression of lipogenic enzymes both in the liver and white adipose tissue. C57BL/6 male
mice at 8 weeks of age were treated with PBS vs. leptin (2 mg/kg) via intraperitoneal (i.p.) injection twice a day for 4 days, and were sacrificed 5 hours
after the last injection. (A) Food intake and (B) body weight were measured daily before the dark cycle, and arrows indicate the time points of leptin
injections. (C) Western immunoblots showing leptin-stimulated activation of STAT3 in the hypothalamus, liver and white adipose tissue, as detected
by the indicated antibodies. (D) The triglyceride (TG) levels both in the serum and liver were measured after leptin administration. (E–F) Protein levels
of ACL and FAS in the liver (E) and WAT (F) were analyzed by Western immunoblot, with quantification results shown in the bar graphs. Data in all
panels are presented as mean6SEM (n=4–5/group);
*p,0.05 vs. PBS-treatment group.
doi:10.1371/journal.pone.0006884.g005
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Mouse Adipocyte LINCOplex Kit (LINCO Research), respec-
tively, according to manufacturer’s instructions.
Antibodies and Western immunoblot analysis
Monoclonal FAS antibody was purchased from BD Biosciences;
ACL, STAT3 and phospho-STAT3 antibodies were from Cell
Signaling; GAPDH antibody was from KANGCHEN; Monoclo-
nal antibody against tubulin was from Sigma. For Western
immunoblotting, tissue extracts were prepared by lysis with
CelLytic
TM MT (Sigma) and centrifuged for 20 min at 20,000 g
to remove the debris. Proteins (20,40 mg) were separated by
SDS-PAGE and transferred to PVDF filter membrane (Amersham
Biosciences). After incubation with the desired antibodies, the blots
were developed using Amersham’s ECL-plus Detection System.
Quantitative RT-PCR analysis
Epididymal fat pads from mice fed LFD vs. VHFD were
removed and snap-frozen immediately in liquid nitrogen for
subsequent RNA extraction with TRIzol reagent (Invitrogen,
Carlsbad, CA). Reverse transcription was done using M-MLV
reverse transcriptase and random hexamer primers (Invitrogen).
Real-time quantitative PCR was performed with ABI Prism 7500
Sequence Detection System according to manufacture’s recom-
mendations (Applied Biosystems), with GAPDH used as an
internal control for normalization and the following oligonucleo-
tide primers for each target gene:
ACL, 59-TGGATGCCACAGCTGACTAC-39 and 59-GGTT-
CAGCAAGGTCAGCTTC-39;
FAS, 59AAGTTGCCCGAGTCAGAGAA-39 and 59-CGTC-
GAACTTGGAGAGATCC-39;
Statistical analysis
Data are presented as mean6SEM. Differences were analyzed
by unpaired two-tailed t-test between two groups or otherwise by
one-way ANOVA.
Supporting Information
Table S1 Proteins with altered expression in the WAT of the
HFD-fed mice at 16 weeks Numbers with ‘‘-’’ indicate fold
decreases in the VHFD-fed group, or fold increases otherwise.
Quantification was done with the ImageMaster 2D Elite Software
(Amersham Biosciences).
Found at: doi:10.1371/journal.pone.0006884.s001 (0.05 MB
DOC)
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